Cargando…
Combating Ebola with Repurposed Therapeutics Using the CANDO Platform
Ebola virus disease (EVD) is extremely virulent with an estimated mortality rate of up to 90%. However, the state-of-the-art treatment for EVD is limited to quarantine and supportive care. The 2014 Ebola epidemic in West Africa, the largest in history, is believed to have caused more than 11,000 fat...
Autores principales: | Chopra, Gaurav, Kaushik, Sashank, Elkin, Peter L., Samudrala, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958544/ https://www.ncbi.nlm.nih.gov/pubmed/27898018 http://dx.doi.org/10.3390/molecules21121537 |
Ejemplares similares
-
Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform
por: Hudson, Matthew L., et al.
Publicado: (2021) -
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
por: Mangione, William, et al.
Publicado: (2022) -
Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design
por: Mangione, William, et al.
Publicado: (2019) -
Exploration of interaction scoring criteria in the CANDO platform
por: Falls, Zackary, et al.
Publicado: (2019) -
Fingerprinting CANDO: Increased Accuracy with Structure-
and Ligand-Based Shotgun Drug Repurposing
por: Schuler, James, et al.
Publicado: (2019)